Shaghayegh Aliabadi MD, FACS

Shaghayegh Aliabadi MD, FACS

TEL: 503-281-0561
FAX: 503-416-7377

“It’s rewarding that patients trust me with their health and with the person they are. There’s an instant intimacy where I’m part of their family and one of their friends, and they share things about their lives, their hopes, and their fears.”

Dr. Shaghayegh Aliabadi focuses on thyroid and parathyroid surgery as well as management of breast cancer. Whenever possible, she emphasizes a minimally invasive approach to treatment of endocrine diseases. She is very interested in surgical care improvement outcomes to optimize patient care. Over the years, she has been active in the American Association of Endocrine Surgeons, serving on various committees, and contributing as co-director of advanced endocrine surgery courses.

When not working, Dr. Aliabadi enjoys hiking, floral arranging, and Rummikub.

Volunteer Activities

Project Access NOW

Other Activities

Fellow, American College of Surgeons

Member, American Association of Endocrine Surgeons

Member, American Society of Breast Surgeons

Member, Pacific Coast Surgical Association

For additional information regarding thyroid and parathyroid disease, refer to www.thyroid.org and www.collectedmed.com/aaespatienteducation.

EDUCATION & TRAINING

Residency, Surgery, Henry Ford Hospital, Detroit, MI, 2001

MD, Tulane University School of Medicine, New Orleans, LA, 1995

BS, Biochemistry, University of California, Davis, Davis, CA, 1990

BOARD CERTIFICATION

General Surgery

LEADERSHIP

Board of Directors, Providence Portland Medical Center Foundation, 2020-2023

Director, General Surgery, Portland Providence Medical Center, 2007-2017

Regional Director, Oregon Surgery Program, 2012-2016

Chief of Surgery, Portland Providence Medical Center, 2007-2009

HONORS

Portland Monthly Magazine, “Top Doctors,” 2011, 2013, 2014, 2016, 2018, 2019, 2022, 2023, 2024

Publications

Pothuri V, Anzelmo M, Gallaher E, Ogunlana Y, Aliabadi-Wahle S, Tan B, Crippin J, Hammill C. Transgender Males on Gender-Affirming Hormone Therapy and Hepatobiliary Neoplasms: A Systematic Review. Endocrine Practice. 2023 June.

Ghazizadeh S, Kelly TL, Khajanchee YS, Fleser J, Rozenfeld Y, Neuman M, Hammill CW, Orr L, Aliabadi-Wahle S. Standardization of thyroid ultrasound reporting in the community setting decreases biopsy rates. Clin Endocrinol (Oxf). 2021 Feb 2. doi: 10.1111/cen.14431. Epub ahead of print. PMID: 33529386.

Sharata A, Kelly T, Rozenfeld Y, Hammill C, Schuman E, Carlisle J, Aliabadi-Wahle S, Management of Primary Hyperparathyroidism: Can We Do Better? The American Surgeon. Jan 2017.

Aliabadi-Wahle S., Kelley, T. et al, Treatment Strategies for Primary Hyperparathyroidism: What is the Cost? The American Surgeon. Nov 2014, 80(11): 1146-51.

Sherata A, Aliabadi-Wahle S., Bhayani, N., Kurian, A., Reavis, K., Dunst, C., Swanstrom, L., Subxyphoid Thyroidectomy: A Feasibility Study. Surgical Innovations. April 2014, 21: 194-197.